Analytical Data
-
Gene name
PIP/GCDFP-15
- Application
-
Alternative Names
Gross cystic disease fluid protein 15
-
Species
Human
-
Source
Yeast
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P12273
-
Expression Region
29-146aa
-
Molecular Weight
16 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The recombinant protein PIP/GCDFP-15 (prolactin-inducible protein/Glandular Clusters of Differentiated Fibroblasts Protein 15) has garnered significant attention in biomedical research due to its potential roles in various physiological and pathological processes. Initially identified as a lactation-associated protein, PIP/GCDFP-15 is primarily expressed in mammary glands and has been implicated in breast cancer development and progression. The protein shows promise as a biomarker for certain types of breast lesions, aiding in differential diagnosis. Furthermore, studies suggest that PIP/GCDFP-15 may have involvement in inflammation, immune response, and tissue remodeling, making it a candidate for understanding diseases beyond oncology, including autoimmune disorders and wound healing. Recent advancements in recombinant DNA technology have facilitated the production of high-purity PIP/GCDFP-15, allowing for detailed characterization and functional studies. Researchers aim to elucidate its molecular mechanisms and potential therapeutic applications, thus expanding the scientific community's understanding of its biological significance and paving the way for novel diagnostic and treatment strategies.
